Under the terms of the agreement, Garden State Nutritionals (GSN) will manufacture and deliver a powerful and proprietary anti-aging, antioxidant nutritional supplement for the company.
The company will market this unique new supplement through the operations of Medical Technologies Enterprises. The company has recently assumed the operations of Med Tech Enterprises and will continue to investigate, research and introduce new offerings as unique and effective products are developed.
Larry Hooper, CEO and president of Cardiovascular Sciences, said: “We have formulated a very complete, unique and comprehensive antioxidant supplement. The specific formulation allows us to legitimately claim beneficial medical effects.”